Research and Development Center
Testing the effectiveness of disinfectants at the MEDISEPT Research and Development Center
State-of-the-art laboratories, a team of experienced experts, accredited methods, and comprehensive service
The MEDISEPT Research and Development Center is working on its Research Agenda. The project is titled: “Development of formulations for innovative disinfection products with a maximally reduced amount of active substances (compared to products currently available on the market) and effective, among other things, against the bacterial biofilm of antibiotic-resistant bacteria.”
The complex was built next to the company’s headquarters in a special economic zone and employs leading specialists in its field.
The MEDISEPT Research and Development Center includes, among other facilities, a virology and microbiology laboratory, whose purpose is to support the company in creating even more effective products. The facility enables the conduct of tests, stability studies, and the implementation of innovations. The center also provides commercial services.
LABORATORY (BIOSAFETY LEVEL 2)
In the BSL-2 in vitro cell culture laboratory, we work with various cell lines. We currently culture mammalian cell lines (Vero, RAW), including human cell lines (HeLa). Vero cells were isolated from the renal epithelial tissue of the green-eyed guinea pig, while RAW cells originate from a mouse tumor. HeLa cells are the first immortalized human cell line isolated from cervical cancer cells.
In our BSL-2 virology laboratory, we conduct tests on the virucidal efficacy of disinfectants in accordance with EN 14885 for the testing of chemical disinfectants and antiseptics. We conduct efficacy tests of products against enveloped viruses (Vaccinia Virus) and limited virucidal activity on test models: Adenovirus and Murine Norovirus. Additionally, we conduct tests of disinfectants used in the veterinary field using Bovine Enterovirus (ECBO).
Virological testing performed in accordance with:
Quantitative suspension method for determining virucidal activity in the medical field
(Phase 2/Stage 1)
Chemical disinfectants and antiseptics — Quantitative carrier method for determining virucidal activity for instruments used in the medical field
(Phase 2, Step 2)
Chemical disinfectants and antiseptics — Quantitative surface method for determining the virucidal activity of chemical disinfectants used in the medical field on non-porous surfaces, without mechanical action
(Phase 2, Stage 2)
Quantitative suspension method for determining the virucidal activity of chemical disinfectants and antiseptics used in the veterinary field
(Phase 2/Stage 1)
Chemical disinfectants and antiseptics — Quantitative surface method for determining the virucidal activity of chemical disinfectants and antiseptics used in the veterinary field on non-porous surfaces
(Phase 2, Stage 2)
LABORATORY (BIOSAFETY LEVEL 2)
In our BSL-2 microbiological laboratory, we conduct tests on the bactericidal and fungicidal efficacy of disinfectants in accordance with EN 14885 regarding the testing of chemical disinfectants and antiseptics. We perform these tests using reference strains of bacteria and fungi from the American ATCC collection.
Microbiological testing performed in accordance with:
Quantitative suspension method for determining fungicidal or yeasticidal activity in the medical field
(Phase 2/Stage 1)
Quantitative suspension method for determining the bactericidal activity in the medical field
(Phase 2/Stage 1)
Quantitative method for determining the bactericidal and fungicidal activity of chemical disinfectants used in the food sector, industrial and domestic settings, and public facilities on non-porous surfaces
(Phase 2/Stage 2)
Chemical disinfectants and antiseptics – Quantitative suspension test for the bactericidal activity of chemical disinfectants and antiseptics used in the veterinary field
(Phase 2/Stage 1)
Chemical disinfectants and antiseptics – Quantitative suspension method for determining the fungicidal or yeasticidal activity of chemical disinfectants and antiseptics used in the veterinary field
(Phase 2/Stage 1)
Chemical disinfectants and antiseptics – Quantitative surface method for determining the bactericidal activity of chemical disinfectants and antiseptics used in the veterinary field on non-porous surfaces, without mechanical action
(Phase 2/Stage 2)
Chemical disinfectants and antiseptics – Quantitative surface method for determining the fungicidal or yeasticidal activity of chemical disinfectants and antiseptics used in the veterinary field on non-porous surfaces, without mechanical action
(Phase 2/Stage 2)
BIOCIDE PRODUCT TESTING
Suspension - viruses (phase 2, stage 1) + virucidal activity against ASFV
Surfaces - viruses (phase 2, stage 2)
Suspension - bacteria (phase 2, stage 1)
Suspension - fungi (phase 2, stage 1)
Surfaces - bacteria (phase 2, stage 2)
Surfaces - fungi (phase 2, stage 2)
Porous surfaces - bacteria (phase 2, stage 2)
Aerosol - viruses (phase 2, stage 1)
Surfaces - viruses (phase 2, stage 2)
Tools - viruses (phase 2, stage 2)
Aerosol - bacteria (phase 2, stage 1)
Aerosol - fungi (phase 2, stage 1)
Surfaces - bacteria and fungi (phase 2, stage 2)
Tools - bacteria (phase 2, stage 2)
Tools - fungi (phase 2, stage 2)
4-pole test - bacteria, yeasts (phase 2, stage 2)
Surfaces - bacteria and fungi (phase 2, stage 2)
Suspension - bacteria (phase 2, stage 1)
Suspension - fungi (phase 2, stage 1)
Biocidal activity - Legionella (phase 2, stage 1)
Room fogging - viruses, bacteria, fungi Dry Disinfection Test
About CBR
Gallery
cbr@medisept.pl
